New asthma jab receives NICE backing

GPs should refer patients with severe asthma to specialist care for treatment with omalizumab (Xolair), according to latest NICE guidance.

The NICE technology appraisal recommends the use of omalizumab for the treatment of severe persistent allergic asthma in adults and adolescents over the age of 12.

It is estimated that around 6,000 patients UK-wide will be able to benefit from the drug, which is already available in Scotland.

Patients in England and Wales can expect the drug to become available within the next three months, with confirmation that the drug will be made available in Northern Ireland expected next month. 

Omalizumab, which is given as a jab twice a month, should only be initiated if the patient has confirmation of IgE mediated allergy to a perennial allergen by clinical history and allergy skin testing.

GPs should only refer patients for the treatment if they have suffered either two or more severe asthma attacks requiring hospital admission within the previous year, and a further two which required treatment or monitoring in excess of the patient’s usual regimen.

Treatment should be stopped if patients fail to show any adequate response after 16 weeks.

sanjay.tanday@haymarket.com

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Some patients with post-COVID problems may need months of support from GPs

Some patients with post-COVID problems may need months of support from GPs

GPs must be ready to support patients with physical, psychological and social problems...

BMA demands 'rule of six' overhaul to prevent further lockdowns

BMA demands 'rule of six' overhaul to prevent further lockdowns

The government must scrap its high-risk ‘rule of six’ and introduce more stringent...

Average GP practice list tops 9,000 after 30% rise in seven years

Average GP practice list tops 9,000 after 30% rise in seven years

The average GP practice list has risen beyond 9,000 patients for the first time after...

GP dilemma: What should I do if a parent sends their child with COVID-19 symptoms to school?

GP dilemma: What should I do if a parent sends their child with COVID-19 symptoms to school?

Medical Protection's Dr Clare Devlin offers advice on how GPs should respond to parents...

GPs risk missing out on vital COVID-19 risk assessments, BMA warns

GPs risk missing out on vital COVID-19 risk assessments, BMA warns

GPs risk missing out on COVID-19 risk assessments unless practices are guaranteed...

GPs call for partial suspension of network DES amid heavy workload

GPs call for partial suspension of network DES amid heavy workload

GPs leading primary care networks (PCNs) have called for the partial suspension of...